smashopf.blogg.se

Journey 2024 by Atos Scientific Community
Journey 2024 by Atos Scientific Community











Journey 2024 by Atos Scientific Community

Cellular level in-silico modeling of blood rheology with an improved material model for red blood cells.

Journey 2024 by Atos Scientific Community

In this way, virtual humans will not only assist medical staff to prescribe the best, least-invasive treatments, they will also help clinicians and scientists to predict, pre-empt and prevent illness from even occurring.ġ Závodszky G, van Rooij B, Azizi V, Hoekstra A.

Journey 2024 by Atos Scientific Community Journey 2024 by Atos Scientific Community

In a supercomputer, many virtual versions of an individual can exist simultaneously so that doctors can model the impacts of small changes in lifestyles and medications on health, ageing and quality of life, and to predict the risk of strokes, for example. With a patient’s very own avatar moving exactly as they do, clinicians will be able to calculate the forces and mechanical stresses placed on their bones in order to predict the risk of fracture. In future, virtual humans will help doctors to plan procedures, such as brain surgery, in order to test different approaches and implants successfully in a digital environment. It is in the process of establishing a Center of Excellence for simulating the different processes of the human body and making those available to clinicians and organizations across the healthcare and medical science domain.Īs a member of the consortium, we help optimize simulation applications using high performance computing (HPC) capabilities to process vast, complex data and edge computing facilities to take that processed data and turn it into real-time visualizations that are accurate and intricate at every scale. The Virtual Human Project is being developed and delivered by CompBioMed, a consortium led by University College London as part of the European Commission’s H2020 initiative, and it is coordinated by Professor Peter Coveney. And with cardiovascular disease accounting for half the sudden deaths in Europe, in future, virtual hearts beating inside supercomputers will reveal the detailed workings of individual patients to better understand the disease and test the effects of different drugs and pacemakers. Simulating a patient’s circulatory system and the movement of red blood cells produces insights into important processes such as those that prevent blood loss after an injury. Using a patient’s own individual avatar, clinicians and researchers can test the effects of different drugs in order to select the most effective and clinicians and device manufacturers can visualize how best to deliver a drug exactly where it is most needed.













Journey 2024 by Atos Scientific Community